A protocol for the retina surgeon’s safe initial intravitreal injections
Ronald EP Frenkel1,2, Shamim A Haji1,2, Melvin La1, Max PC Frenkel1, Angela Reyes11Eye Research Foundation, Stuart, FL, USA; 2East Florida Eye Institute, Stuart, FL, USAPurpose: To determine the safety of a surgeon’s initial consecutive intravitreal injections using a specific protocol...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/72d8a52179304eb4b8b2ad032a755467 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:72d8a52179304eb4b8b2ad032a755467 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:72d8a52179304eb4b8b2ad032a7554672021-12-02T04:53:51ZA protocol for the retina surgeon’s safe initial intravitreal injections1177-54671177-5483https://doaj.org/article/72d8a52179304eb4b8b2ad032a7554672010-11-01T00:00:00Zhttp://www.dovepress.com/a-protocol-for-the-retina-surgeonrsquos-safe-initial-intravitreal-inje-a5630https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Ronald EP Frenkel1,2, Shamim A Haji1,2, Melvin La1, Max PC Frenkel1, Angela Reyes11Eye Research Foundation, Stuart, FL, USA; 2East Florida Eye Institute, Stuart, FL, USAPurpose: To determine the safety of a surgeon’s initial consecutive intravitreal injections using a specific protocol and to review the complications that may be attributed to the injection procedure.Design: A retrospective chart review.Participants: Fifty-nine patients (30 females, 29 males) received intravitreal injections of pegaptanib, bevacizumab, or ranibizumab as part of their treatment for neovascular age-related macular degeneration. The average patient age was 80 years. Twenty-two patients were diagnosed with or suspected of having glaucoma. Each patient received an average of 5.8 injections.Methods: The charts of 59 patients who received a total of 345 intravitreal injections (104 pegaptanib, 74 bevacizumab, 167 ranibizumab) were reviewed. All injections were performed in an office-based setting. Povidone–iodine, topical antibiotics, and eye speculum were used as part of the pre injection procedure. Vision and intraocular pressure were evaluated immediately following each injection.Main outcome measures: Incidence of post injection complications, including but not limited to endophthalmitis, retinal detachment, traumatic cataract, and vitreous hemorrhage.Results: There were no cases of endophthalmitis, toxic reactions, traumatic cataracts, retinal detachment, or vitreous hemorrhage. There was one case each of lid swelling, transient floaters, retinal pigment epithelial tear, corneal edema, and corneal abrasion. There were five cases of transient no light perception following pegaptanib injections.Conclusion: The incidence of serious complications was very low for the intravitreal injections given. A surgeon’s initial intravitreal injections may be performed with a very high degree of safety using this protocol.Keywords: intravitreal injection, post injection complications, intraocular disease, age-related macular degeneration, bevacizumab, endophthalmitis, pegaptanib, ranibizumab Ronald EP FrenkelShamim A HajiMelvin Laet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2010, Iss default, Pp 1279-1285 (2010) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Ophthalmology RE1-994 |
| spellingShingle |
Ophthalmology RE1-994 Ronald EP Frenkel Shamim A Haji Melvin La et al A protocol for the retina surgeon’s safe initial intravitreal injections |
| description |
Ronald EP Frenkel1,2, Shamim A Haji1,2, Melvin La1, Max PC Frenkel1, Angela Reyes11Eye Research Foundation, Stuart, FL, USA; 2East Florida Eye Institute, Stuart, FL, USAPurpose: To determine the safety of a surgeon’s initial consecutive intravitreal injections using a specific protocol and to review the complications that may be attributed to the injection procedure.Design: A retrospective chart review.Participants: Fifty-nine patients (30 females, 29 males) received intravitreal injections of pegaptanib, bevacizumab, or ranibizumab as part of their treatment for neovascular age-related macular degeneration. The average patient age was 80 years. Twenty-two patients were diagnosed with or suspected of having glaucoma. Each patient received an average of 5.8 injections.Methods: The charts of 59 patients who received a total of 345 intravitreal injections (104 pegaptanib, 74 bevacizumab, 167 ranibizumab) were reviewed. All injections were performed in an office-based setting. Povidone–iodine, topical antibiotics, and eye speculum were used as part of the pre injection procedure. Vision and intraocular pressure were evaluated immediately following each injection.Main outcome measures: Incidence of post injection complications, including but not limited to endophthalmitis, retinal detachment, traumatic cataract, and vitreous hemorrhage.Results: There were no cases of endophthalmitis, toxic reactions, traumatic cataracts, retinal detachment, or vitreous hemorrhage. There was one case each of lid swelling, transient floaters, retinal pigment epithelial tear, corneal edema, and corneal abrasion. There were five cases of transient no light perception following pegaptanib injections.Conclusion: The incidence of serious complications was very low for the intravitreal injections given. A surgeon’s initial intravitreal injections may be performed with a very high degree of safety using this protocol.Keywords: intravitreal injection, post injection complications, intraocular disease, age-related macular degeneration, bevacizumab, endophthalmitis, pegaptanib, ranibizumab |
| format |
article |
| author |
Ronald EP Frenkel Shamim A Haji Melvin La et al |
| author_facet |
Ronald EP Frenkel Shamim A Haji Melvin La et al |
| author_sort |
Ronald EP Frenkel |
| title |
A protocol for the retina surgeon’s safe initial intravitreal injections |
| title_short |
A protocol for the retina surgeon’s safe initial intravitreal injections |
| title_full |
A protocol for the retina surgeon’s safe initial intravitreal injections |
| title_fullStr |
A protocol for the retina surgeon’s safe initial intravitreal injections |
| title_full_unstemmed |
A protocol for the retina surgeon’s safe initial intravitreal injections |
| title_sort |
protocol for the retina surgeon’s safe initial intravitreal injections |
| publisher |
Dove Medical Press |
| publishDate |
2010 |
| url |
https://doaj.org/article/72d8a52179304eb4b8b2ad032a755467 |
| work_keys_str_mv |
AT ronaldepfrenkel aprotocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT shamimahaji aprotocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT melvinla aprotocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT etal aprotocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT ronaldepfrenkel protocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT shamimahaji protocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT melvinla protocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections AT etal protocolfortheretinasurgeonamprsquossafeinitialintravitrealinjections |
| _version_ |
1718401013304524800 |